10.1111/liv.12046 35 GumS
Blood glucose levels should be monitored, and the reduction of existing blood glucose-lowering drugs should be considered
Although our small cohort was underpowered to assess the impact of these quantitative atherosclerotic changes on clinical outcomes, these mechanisms may at least partially explain the treatment effects associated with GLP-1Ra in large-scale RCTs
Retatrutide is the research name for LY3437943, an investigational peptide designed as a single molecule with agonist activity at three receptor systems: GIP, GLP-1, and glucagon
Tandon and his team provide detailed postoperative guidance and closely monitor each patients progress throughout the recovery process
It can also increase the risk of hypoglycaemia (low blood sugar), so it should be consumed with extreme caution and always with food